Logo image of ALS.CA

ALTIUS MINERALS CORPORATION (ALS.CA) Stock Fundamental Analysis

Canada - TSX:ALS - CA0209361009 - Common Stock

33.86 CAD
+0.19 (+0.56%)
Last: 10/3/2025, 7:00:00 PM
Fundamental Rating

6

Overall ALS gets a fundamental rating of 6 out of 10. We evaluated ALS against 818 industry peers in the Metals & Mining industry. While ALS has a great profitability rating, there are some minor concerns on its financial health. ALS has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year ALS was profitable.
ALS had a positive operating cash flow in the past year.
Of the past 5 years ALS 4 years were profitable.
ALS had a positive operating cash flow in each of the past 5 years.
ALS.CA Yearly Net Income VS EBIT VS OCF VS FCFALS.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

With an excellent Return On Assets value of 13.83%, ALS belongs to the best of the industry, outperforming 94.74% of the companies in the same industry.
ALS has a better Return On Equity (17.37%) than 94.25% of its industry peers.
With an excellent Return On Invested Capital value of 1.84%, ALS belongs to the best of the industry, outperforming 89.49% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for ALS is significantly below the industry average of 12.11%.
Industry RankSector Rank
ROA 13.83%
ROE 17.37%
ROIC 1.84%
ROA(3y)6.72%
ROA(5y)4.23%
ROE(3y)9.21%
ROE(5y)5.89%
ROIC(3y)3.48%
ROIC(5y)3.42%
ALS.CA Yearly ROA, ROE, ROICALS.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

ALS has a Profit Margin of 210.11%. This is amongst the best in the industry. ALS outperforms 99.39% of its industry peers.
In the last couple of years the Profit Margin of ALS has grown nicely.
The Operating Margin of ALS (41.65%) is better than 97.80% of its industry peers.
ALS's Operating Margin has been stable in the last couple of years.
ALS has a better Gross Margin (88.04%) than 99.63% of its industry peers.
ALS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 41.65%
PM (TTM) 210.11%
GM 88.04%
OM growth 3Y-0.25%
OM growth 5Y1.35%
PM growth 3Y52.38%
PM growth 5Y43.37%
GM growth 3Y-1.17%
GM growth 5Y-0.41%
ALS.CA Yearly Profit, Operating, Gross MarginsALS.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALS is destroying value.
Compared to 1 year ago, ALS has less shares outstanding
ALS has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ALS has a worse debt to assets ratio.
ALS.CA Yearly Shares OutstandingALS.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ALS.CA Yearly Total Debt VS Total AssetsALS.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 6.80 indicates that ALS is not in any danger for bankruptcy at the moment.
ALS has a Altman-Z score of 6.80. This is in the better half of the industry: ALS outperforms 63.81% of its industry peers.
ALS has a debt to FCF ratio of 5.08. This is a neutral value as ALS would need 5.08 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 5.08, ALS belongs to the best of the industry, outperforming 90.95% of the companies in the same industry.
ALS has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
ALS has a worse Debt to Equity ratio (0.16) than 65.89% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 5.08
Altman-Z 6.8
ROIC/WACC0.22
WACC8.5%
ALS.CA Yearly LT Debt VS Equity VS FCFALS.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

ALS has a Current Ratio of 2.35. This indicates that ALS is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ALS (2.35) is comparable to the rest of the industry.
A Quick Ratio of 2.35 indicates that ALS has no problem at all paying its short term obligations.
With a Quick ratio value of 2.35, ALS perfoms like the industry average, outperforming 57.09% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.35
Quick Ratio 2.35
ALS.CA Yearly Current Assets VS Current LiabilitesALS.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

3

3. Growth

3.1 Past

The earnings per share for ALS have decreased strongly by -29.63% in the last year.
The earnings per share for ALS have been decreasing by -13.58% on average. This is quite bad
The Revenue for ALS has decreased by -24.35% in the past year. This is quite bad
ALS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.01% yearly.
EPS 1Y (TTM)-29.63%
EPS 3Y-32.81%
EPS 5Y-13.58%
EPS Q2Q%-66.67%
Revenue 1Y (TTM)-24.35%
Revenue growth 3Y-10.7%
Revenue growth 5Y-1.01%
Sales Q2Q%-49.66%

3.2 Future

Based on estimates for the next years, ALS will show a very strong growth in Earnings Per Share. The EPS will grow by 24.80% on average per year.
Based on estimates for the next years, ALS will show a small growth in Revenue. The Revenue will grow by 7.95% on average per year.
EPS Next Y2.25%
EPS Next 2Y32.8%
EPS Next 3Y33.08%
EPS Next 5Y24.8%
Revenue Next Year-14.54%
Revenue Next 2Y1.71%
Revenue Next 3Y1.28%
Revenue Next 5Y7.95%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALS.CA Yearly Revenue VS EstimatesALS.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20M 40M 60M 80M 100M
ALS.CA Yearly EPS VS EstimatesALS.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.2 0.4 0.6 0.8

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 178.21, which means the current valuation is very expensive for ALS.
85.57% of the companies in the same industry are more expensive than ALS, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.90. ALS is valued rather expensively when compared to this.
With a Price/Forward Earnings ratio of 71.11, ALS can be considered very expensive at the moment.
86.80% of the companies in the same industry are more expensive than ALS, based on the Price/Forward Earnings ratio.
ALS's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.36.
Industry RankSector Rank
PE 178.21
Fwd PE 71.11
ALS.CA Price Earnings VS Forward Price EarningsALS.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALS is valued cheaply inside the industry as 88.88% of the companies are valued more expensively.
90.83% of the companies in the same industry are more expensive than ALS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 78.58
EV/EBITDA 65.58
ALS.CA Per share dataALS.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
ALS has an outstanding profitability rating, which may justify a higher PE ratio.
ALS's earnings are expected to grow with 33.08% in the coming years. This may justify a more expensive valuation.
PEG (NY)79.36
PEG (5Y)N/A
EPS Next 2Y32.8%
EPS Next 3Y33.08%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.19%, ALS has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 9.91, ALS pays a better dividend. On top of this ALS pays more dividend than 97.19% of the companies listed in the same industry.
With a Dividend Yield of 1.19, ALS pays less dividend than the S&P500 average, which is at 2.44.
Industry RankSector Rank
Dividend Yield 1.19%

5.2 History

The dividend of ALS has a limited annual growth rate of 0.59%.
ALS has been paying a dividend for at least 10 years, so it has a reliable track record.
ALS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.59%
Div Incr Years4
Div Non Decr Years4
ALS.CA Yearly Dividends per shareALS.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

ALS pays out 15.18% of its income as dividend. This is a sustainable payout ratio.
The dividend of ALS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP15.18%
EPS Next 2Y32.8%
EPS Next 3Y33.08%
ALS.CA Yearly Income VS Free CF VS DividendALS.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M
ALS.CA Dividend Payout.ALS.CA Dividend Payout, showing the Payout Ratio.ALS.CA Dividend Payout.PayoutRetained Earnings

ALTIUS MINERALS CORPORATION

TSX:ALS (10/3/2025, 7:00:00 PM)

33.86

+0.19 (+0.56%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)08-11 2025-08-11/amc
Earnings (Next)11-05 2025-11-05
Inst Owners20.1%
Inst Owner ChangeN/A
Ins Owners5.34%
Ins Owner ChangeN/A
Market Cap1.57B
Analysts78.18
Price Target36.65 (8.24%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.19%
Yearly Dividend0.32
Dividend Growth(5Y)0.59%
DP15.18%
Div Incr Years4
Div Non Decr Years4
Ex-Date08-29 2025-08-29 (0.1)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-27.51%
Min EPS beat(2)-29.28%
Max EPS beat(2)-25.74%
EPS beat(4)1
Avg EPS beat(4)-16.37%
Min EPS beat(4)-29.28%
Max EPS beat(4)18.81%
EPS beat(8)2
Avg EPS beat(8)-16.05%
EPS beat(12)2
Avg EPS beat(12)-23.29%
EPS beat(16)3
Avg EPS beat(16)-14.98%
Revenue beat(2)0
Avg Revenue beat(2)-14.07%
Min Revenue beat(2)-22.8%
Max Revenue beat(2)-5.33%
Revenue beat(4)0
Avg Revenue beat(4)-13.87%
Min Revenue beat(4)-22.8%
Max Revenue beat(4)-5.33%
Revenue beat(8)2
Avg Revenue beat(8)-10.26%
Revenue beat(12)3
Avg Revenue beat(12)-7.39%
Revenue beat(16)5
Avg Revenue beat(16)-5.31%
PT rev (1m)0.6%
PT rev (3m)7.25%
EPS NQ rev (1m)2.09%
EPS NQ rev (3m)-9.26%
EPS NY rev (1m)0%
EPS NY rev (3m)-11.83%
Revenue NQ rev (1m)-1.97%
Revenue NQ rev (3m)-1.97%
Revenue NY rev (1m)-4.28%
Revenue NY rev (3m)-9.01%
Valuation
Industry RankSector Rank
PE 178.21
Fwd PE 71.11
P/S 33.19
P/FCF 78.58
P/OCF 70.95
P/B 2.74
P/tB 2.74
EV/EBITDA 65.58
EPS(TTM)0.19
EY0.56%
EPS(NY)0.48
Fwd EY1.41%
FCF(TTM)0.43
FCFY1.27%
OCF(TTM)0.48
OCFY1.41%
SpS1.02
BVpS12.34
TBVpS12.34
PEG (NY)79.36
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 13.83%
ROE 17.37%
ROCE 2.78%
ROIC 1.84%
ROICexc 1.87%
ROICexgc 1.87%
OM 41.65%
PM (TTM) 210.11%
GM 88.04%
FCFM 42.24%
ROA(3y)6.72%
ROA(5y)4.23%
ROE(3y)9.21%
ROE(5y)5.89%
ROIC(3y)3.48%
ROIC(5y)3.42%
ROICexc(3y)3.89%
ROICexc(5y)3.81%
ROICexgc(3y)3.89%
ROICexgc(5y)3.82%
ROCE(3y)5.26%
ROCE(5y)5.17%
ROICexcg growth 3Y-14.71%
ROICexcg growth 5Y-5.44%
ROICexc growth 3Y-14.71%
ROICexc growth 5Y-5.14%
OM growth 3Y-0.25%
OM growth 5Y1.35%
PM growth 3Y52.38%
PM growth 5Y43.37%
GM growth 3Y-1.17%
GM growth 5Y-0.41%
F-Score5
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 5.08
Debt/EBITDA 3.69
Cap/Depr 38.31%
Cap/Sales 4.54%
Interest Coverage 2.43
Cash Conversion 87.43%
Profit Quality 20.1%
Current Ratio 2.35
Quick Ratio 2.35
Altman-Z 6.8
F-Score5
WACC8.5%
ROIC/WACC0.22
Cap/Depr(3y)21.45%
Cap/Depr(5y)17.13%
Cap/Sales(3y)3.12%
Cap/Sales(5y)3.13%
Profit Quality(3y)194.6%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-29.63%
EPS 3Y-32.81%
EPS 5Y-13.58%
EPS Q2Q%-66.67%
EPS Next Y2.25%
EPS Next 2Y32.8%
EPS Next 3Y33.08%
EPS Next 5Y24.8%
Revenue 1Y (TTM)-24.35%
Revenue growth 3Y-10.7%
Revenue growth 5Y-1.01%
Sales Q2Q%-49.66%
Revenue Next Year-14.54%
Revenue Next 2Y1.71%
Revenue Next 3Y1.28%
Revenue Next 5Y7.95%
EBIT growth 1Y-34.28%
EBIT growth 3Y-10.93%
EBIT growth 5Y0.32%
EBIT Next Year46.36%
EBIT Next 3Y28.27%
EBIT Next 5Y19.11%
FCF growth 1Y-67.12%
FCF growth 3Y-18.25%
FCF growth 5Y17.22%
OCF growth 1Y-64.63%
OCF growth 3Y-16.08%
OCF growth 5Y0.4%